In 2022, before changing its name from Sema4 to GeneDx, the company had a dispute with UnitedHealthcare, which resulted in a ...

The CagriSema trial, called REDEFINE-1, is crucial to Novo's drug pipeline as the company loses its first mover advantage ...

Investing.com -- Shares of Supermicro, Inc. (NASDAQ: SMCI) climbed 5% after the company announced it had ramped up full ...

Osama Elmasry Njeem was released and flown home to Tripoli two days after being detained last month in northern Italy on the ...

“RACE beat Q4'24 by +7% and exceeded the 'bar' for its 2025 guide with a >€2.03bn EBIT 'floor'," Barclays (LON: BARC) wrote, ...

HELSINKI (Reuters) - The transition from fossil fuels to renewable energy will continue in the U.S. despite President Donald ...

China, with whom Trump has threatened a trade war, is the world's largest producer of rare earths and many other critical ...

The president has recently hit out the EU, accusing the 27-member bloc of having "taken advantage" of the U.S. through a ...

Investing.com -- Husqvarna's (ST: HUSQb) stock dropped by 7% on Wednesday after the company reported a decline in organic ...

(Reuters) - Sweden's Assa Abloy (OTC: ASAZY) plans to raise its prices if U.S. President Donald Trump moves ahead with the ...

CAIRO/GAZA (Reuters) - Gazans criticised U.S. President Donald Trump's plan to take over the Gaza Strip and resettle ...

In a note to clients lifting their rating of the chipmaker to "neutral" from "sell", the analysts noted that consensus ...